Skip to main content
logo
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
19.65
+0.20 (1.03%)
Sep 22, 2025, 3:50 PM EDT - Market open

Schrödinger Revenue by Type

Period EndingJun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Software Products and Services
200.94M200.94M200.94M195.80M195.80M195.80M180.40M180.40M180.40M169.40M169.40M169.40M166.42M166.42M166.42M160.37M160.37M160.37M159.17M159.17M159.17M138.27M138.27M138.27M
Software Products and Services Growth
20.74%20.74%20.74%22.09%22.09%22.09%13.34%13.34%13.34%22.52%22.52%22.52%24.17%24.17%24.17%19.07%19.07%19.07%17.42%17.42%17.42%---
Drug Discovery
37.06M37.06M37.06M34.77M34.77M34.77M27.22M27.22M27.22M24.02M24.02M24.02M34.28M34.28M34.28M28.19M28.19M28.19M57.57M57.57M57.57M61.07M61.07M61.07M
Drug Discovery Growth
8.10%8.10%8.10%23.37%23.37%23.37%-52.72%-52.72%-52.72%-60.67%-60.67%-60.67%-42.60%-42.60%-42.60%-54.79%-54.79%-54.79%26.94%26.94%26.94%---

Software Products and Services Revenue Breakdown

Period EndingJun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022Sep 30, 2022Sep 30, 2022Sep 30, 2022Jun 30, 2022Jun 30, 2022Jun 30, 2022
Software Products and Services
27.13M27.13M27.13M26.27M26.27M26.27M23.32M23.32M23.32M
Software Products and Services Growth
6.96%6.96%6.96%13.80%13.80%13.80%1.39%1.39%1.39%
Software Contribution
16.37M16.37M16.37M13.66M13.66M13.66M---------------------------------
Drug Discovery
9.03M9.03M9.03M7.96M7.96M7.96M8.98M8.98M8.98M
Drug Discovery Growth
7.57%7.57%7.57%-8.59%-8.59%-8.59%-5.58%-5.58%-5.58%

Drug Discovery Revenue Breakdown

Period EndingJun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Drug Discovery Services Customer Contracts
35.12M35.12M35.12M32.69M32.69M32.69M25.14M25.14M25.14M21.97M21.97M21.97M31.88M31.88M31.88M25.61M25.61M25.61M54.72M54.72M54.72M58.22M58.22M58.22M
Drug Discovery Services Customer Contracts Growth
10.16%10.16%10.16%27.64%27.64%27.64%-54.05%-54.05%-54.05%-62.27%-62.27%-62.27%-44.26%-44.26%-44.26%-57.31%-57.31%-57.31%26.00%26.00%26.00%---
Drug Discovery Contribution
1.89M1.89M1.89M2.04M2.04M2.04M2.03M2.03M2.03M2.02M2.02M2.02M2.37M2.37M2.37M2.55M2.55M2.55M2.82M2.82M2.82M2.88M2.88M2.88M
Drug Discovery Contribution Growth
-20.12%-20.12%-20.12%-19.95%-19.95%-19.95%-28.03%-28.03%-28.03%-29.72%-29.72%-29.72%-6.89%-6.89%-6.89%7.24%7.24%7.24%44.72%44.72%44.72%---

Revenue by Geography

Period EndingJun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
United States
124.59M124.59M124.59M121.24M121.24M121.24M114.87M114.87M114.87M133.14M133.14M133.14M141.65M141.65M141.65M134.91M134.91M134.91M161.96M161.96M161.96M146.14M146.14M146.14M
United States Growth
-12.05%-12.05%-12.05%-10.14%-10.14%-10.14%-29.08%-29.08%-29.08%-8.89%-8.89%-8.89%0.83%0.83%0.83%-6.07%-6.07%-6.07%31.08%31.08%31.08%---
EMEA
80.70M80.70M80.70M81.54M81.54M81.54M65.65M65.65M65.65M33.86M33.86M33.86M32.48M32.48M32.48M29.50M29.50M29.50M29.14M29.14M29.14M27.69M27.69M27.69M
EMEA Growth
148.50%148.50%148.50%176.37%176.37%176.37%125.33%125.33%125.33%22.28%22.28%22.28%14.51%14.51%14.51%3.03%3.03%3.03%-15.43%-15.43%-15.43%---
APAC
31.23M31.23M31.23M26.38M26.38M26.38M25.80M25.80M25.80M25.18M25.18M25.18M25.47M25.47M25.47M23.00M23.00M23.00M24.57M24.57M24.57M31.14M31.14M31.14M
APAC Growth
22.62%22.62%22.62%14.69%14.69%14.69%5.02%5.02%5.02%-19.14%-19.14%-19.14%-16.40%-16.40%-16.40%-15.44%-15.44%-15.44%13.33%13.33%13.33%---
Rest of World
1.40M1.40M1.40M1.35M1.35M1.35M1.22M1.22M1.22M1.16M1.16M1.16M1.03M1.03M1.03M1.07M1.07M1.07M1.00M1.00M1.00M-5.59M-5.59M-5.59M
Rest of World Growth
35.43%35.43%35.43%25.94%25.94%25.94%21.68%21.68%21.68%----------21.06%-21.06%-21.06%---
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.